MRI study for NASH diagnosis
Part of Digestive system clinical trials.
This study looks at MRI scans to find better ways to diagnose NASH (a type of fatty liver disease with inflammation). If you are already scheduled for a liver biopsy for suspected NASH, an MRI might help researchers learn more about your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are part of the SNIFF study at Angers Hospital, where your doctor suspects NASH and has ordered a liver biopsy.
- You are 18 years or older.
- You agree to take part (oral consent is fine).
- You do not have any metal implants or other reasons that make MRI unsafe.
- You are not pregnant or breastfeeding.
- You are not in prison, under psychiatric care, or under legal guardianship.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new ultrasound device that uses sound waves to measure fat in the liver without needles or surgery. It is for people with a type of fatty liver disease called MASLD or MASH, who are already getting an MRI to check their liver.
This study checks whether an MRI scan can measure liver health in people with suspected fatty liver disease that may have progressed to NASH. Everyone in the study is also scheduled for a standard liver biopsy, which is used to compare the scan results.
This study checks whether special ultrasound measurements can help diagnose nonalcoholic steatohepatitis (NASH), a type of fatty liver disease. You may need a liver biopsy as part of routine care, and you may also be scanned with MRI to support the study tests.
This study follows people with nonalcoholic fatty liver disease to better understand the condition. It uses an MRI scan and collects body samples to help researchers study changes over time.
This study tests if a new imaging agent (68Ga-FAPI-46) can accurately measure liver scarring (fibrosis) in people with NASH, a type of fatty liver disease. It may offer a way to track liver damage without needing repeated biopsies.
This study uses a new MRI technique to measure how metabolic fatty liver disease affects your body and to track your health over time. It aims to improve understanding of the condition and guide treatment.
Hear when a new Non-alcoholic Fatty Liver Disease NAFLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.